Half-year report · HY
4592.TEDINET S100Z25X
Period2026-02-01 → 2026-07-31
Filed2026-09-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 41
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥1.9bn | 2026-02-01 → 2026-07-31 | Cons. | Operating income |
| Operating income | −¥1.9bn | 2025-02-01 → 2025-07-31 | Cons. | Operating income |
| Ordinary income | −¥1.7bn | 2026-02-01 → 2026-07-31 | Cons. | Ordinary income |
| Ordinary income | −¥4.3bn | 2025-02-01 → 2026-01-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.5bn | 2025-02-01 → 2025-07-31 | Cons. | Ordinary income |
| Profit before tax | −¥1.7bn | 2026-02-01 → 2026-07-31 | Cons. | Income before income taxes |
| Profit before tax | −¥2.5bn | 2025-02-01 → 2025-07-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.8bn | 2026-02-01 → 2026-07-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥3.8bn | 2025-02-01 → 2026-01-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥2.0bn | 2025-02-01 → 2025-07-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.8bn | 2026-02-01 → 2026-07-31 | Cons. | Profit loss |
| Net income | −¥2.0bn | 2025-02-01 → 2025-07-31 | Cons. | Profit loss |
| Total assets | ¥13.6bn | at 2026-07-31 | Cons. | Assets |
| Total assets | ¥15.6bn | at 2026-01-31 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2025-07-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2026-07-31 | Cons. | Liabilities |
| Total liabilities | ¥2.0bn | at 2026-01-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.7bn | at 2026-07-31 | Cons. | Net assets |
| Net assets / equity | ¥13.6bn | at 2026-01-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2025-07-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.7bn | at 2026-07-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.1bn | at 2026-01-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.7bn | at 2026-07-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.8bn | at 2026-01-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.4bn | at 2025-07-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2025-01-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥2.1bn | 2026-02-01 → 2026-07-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥3.8bn | 2025-02-01 → 2026-01-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.1bn | 2025-02-01 → 2025-07-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥78m | 2026-02-01 → 2026-07-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥231m | 2025-02-01 → 2026-01-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥302m | 2025-02-01 → 2025-07-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥112m | 2026-02-01 → 2026-07-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥16.0bn | 2025-02-01 → 2026-01-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2025-02-01 → 2025-07-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-22.95 | 2026-02-01 → 2026-07-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-52.55 | 2025-02-01 → 2026-01-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-27.8 | 2025-02-01 → 2025-07-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 84.0% | at 2026-07-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.4% | at 2026-01-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.5% | at 2025-07-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 408
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | Prior1InterimDuration | Original text (Japanese)当社グループは、他家幹細胞を用いた細胞治療薬事業の単一セグメントであるため、記載を省略しております。 | |
| Description of fact that companys business comprises single segment | InterimDuration | Original text (Japanese)当社グループは、他家幹細胞を用いた細胞治療薬事業の単一セグメントであるため、記載を省略しております。 | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |